Skip to main content
Top
Published in: BMC Infectious Diseases 1/2021

Open Access 01-12-2021 | Ivermectin | Correction

Correction to: Differential susceptibility of Onchocerca volvulus microfilaria to ivermectin in two areas of contrasting history of mass drug administration in Cameroon: relevance of microscopy and molecular techniques for the monitoring of skin microfilarial repopulation within six months of direct observed treatment

Authors: Raphael Awah Abong, Glory N. Amambo, Patrick W. Chounna Ndongmo, Abdel Jelil Njouendou, Manuel Ritter, Amuam Andrew Beng, Mathias Eyong Esum, Kebede Deribe, Jerome Fru-Cho, Fanny F. Fombad, Theobald Mue Nji, Peter Ivo Enyong, Catherine B. Poole, Kenneth Pfarr, Achim Hoerauf, Clotilde K. S. Carlow, Samuel Wanji

Published in: BMC Infectious Diseases | Issue 1/2021

Login to get access

Excerpt

Correction to: BMC Infect Dis 20, 726 (2020)
Literature
1.
go back to reference Abong RA, et al. Differential susceptibility of Onchocerca volvulus microfilaria to ivermectin in two areas of contrasting history of mass drug administration in Cameroon: relevance of microscopy and molecular techniques for the monitoring of skin microfilarial repopulation within six months of direct observed treatment. BMC Infect Dis. 2020;20:726 https://doi.org/10.1186/s12879-020-05444-2.CrossRef Abong RA, et al. Differential susceptibility of Onchocerca volvulus microfilaria to ivermectin in two areas of contrasting history of mass drug administration in Cameroon: relevance of microscopy and molecular techniques for the monitoring of skin microfilarial repopulation within six months of direct observed treatment. BMC Infect Dis. 2020;20:726 https://​doi.​org/​10.​1186/​s12879-020-05444-2.CrossRef
Metadata
Title
Correction to: Differential susceptibility of Onchocerca volvulus microfilaria to ivermectin in two areas of contrasting history of mass drug administration in Cameroon: relevance of microscopy and molecular techniques for the monitoring of skin microfilarial repopulation within six months of direct observed treatment
Authors
Raphael Awah Abong
Glory N. Amambo
Patrick W. Chounna Ndongmo
Abdel Jelil Njouendou
Manuel Ritter
Amuam Andrew Beng
Mathias Eyong Esum
Kebede Deribe
Jerome Fru-Cho
Fanny F. Fombad
Theobald Mue Nji
Peter Ivo Enyong
Catherine B. Poole
Kenneth Pfarr
Achim Hoerauf
Clotilde K. S. Carlow
Samuel Wanji
Publication date
01-12-2021
Publisher
BioMed Central
Keyword
Ivermectin
Published in
BMC Infectious Diseases / Issue 1/2021
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-021-05797-2

Other articles of this Issue 1/2021

BMC Infectious Diseases 1/2021 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.